Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00339664 · ClinicalTrials.gov registry record
Analyses of Human Samples Collected in Clinical Trials
A clinical trial of Prostate Cancer and Neoplasm Metastasis, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 2,579
- Enrollment target
- 17
- Study locations
NCT00339664: Completed study of Prostate Cancer and Neoplasm Metastasis, sponsored by National Cancer Institute (NCI).
NCT00339664 is a study of Prostate Cancer and Neoplasm Metastasis that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 2,579 participants, above the 605-participant average among 735 other Prostate Cancer trials with a reported enrollment target (326% higher). The trial reports 17 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00339664, a study of Prostate Cancer and Neoplasm Metastasis, has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 2,579 participants
- Enrollment target
- 17
- Study locations
Study Summary
Cancer patients in clinical trials donate various human samples (e.g., serum, plasma, blood, urine, feces, bile, saliva) for research purposes. The purpose of this study is to conduct further analyses on these existing samples from clinical trials that are being performed outside of, but in collaboration with, the National Cancer Institute.
Primary Outcome
To quantitate drug and/or metabolite concentrations in human blood samples
Conditions Studied
Study Locations (17)
Maryland
- University of Maryland, Baltimore - Baltimore
- Johns Hopkins Medical Center - Baltimore
- Sidney Kimmel Comprehensive Cancer Center - Baltimore
- National Institutes of Health Clinical Center, 9000 Rockville Pike - Bethesda
Pennsylvania
- University of Maryland at Amish Research Clinic, Lancaster - Lancaster
- Abramson Cancer Center, University of Pennsylvania - Philadelphia
- Hillman Cancer Center at University of Pittsburg Cancer Institute - Pittsburgh
Virginia
- McGuire Veterans Administration Medical Center - Richmond
- Massey Cancer Center, Virginia Commonwealth University - Richmond
Other
- Leiden University Medical Center - Leiden
- Erasmus Medical Center - Rotterdam
District of Columbia
- Childrens National Medical Center - Washington D.C.
Florida
- H. Lee Moffitt Cancer Center & Research Institute - Tampa
Illinois
- University of Chicago - Chicago
Minnesota
- Mayo Clinic, Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,579 participants |
| Start Date | 2003-07-02 |
| Est. Completion | 2020-03-26 |
What the finished NCT00339664 record still lists
NCT00339664 is an observational study that tracks outcomes without assigning an intervention. Its 2,579 participants enrollment target places it among the larger protocols in the corpus, above the 605-participant average among 735 other Prostate Cancer trials with a reported enrollment target (326% higher).
The record links to 4 conditions, with Prostate Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT00339664 lists 17 locations in 10 states (Maryland, Pennsylvania, Virginia).
Frequently Asked Questions
What is clinical trial NCT00339664 about?
NCT00339664 is a clinical study titled "Analyses of Human Samples Collected in Clinical Trials". Cancer patients in clinical trials donate various human samples (e.g., serum, plasma, blood, urine, feces, bile, saliva) for research purposes. The purpose of this study is to conduct further analyses on these existing samples from clinical trials that are being performed outside of, but in collabo...
What is the current status of trial NCT00339664?
This trial is currently completed. The enrollment target is 2,579 participants. The study started on 2003-07-02. Estimated completion is 2020-03-26.
What conditions does trial NCT00339664 study?
This clinical trial studies the following conditions: Prostate Cancer, Neoplasm Metastasis, Leukemia, Myeloid, Leukemia, Lymphoid.
Who is sponsoring clinical trial NCT00339664?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00339664 being conducted?
This trial has 17 study locations across District of Columbia, Florida, Illinois, Maryland, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00339664's enrollment target sits among peer trials
2,579 22nd of 735 higher than 714 of 735 other Prostate Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Prostate Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors
RECRUITING · Phase 1
-
Performance of Inherited Risk Assessment for Predicting Prostate Cancer From Prostate Biopsy
RECRUITING
-
Trial of Neoadjuvant Enoblituzumab vs SOC in Men With High-Risk Localized Prostate Cancer
RECRUITING · Phase 2
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Improving Health Literacy in African-American Prostate Cancer Patients
RECRUITING · NA
-
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06018285 · 2,572 participants · NA
Stepped Approach to Reducing Risk of Suicide in Primary Care
- NCT06370520 · 2,592 participants
Screening Emotions in Adolescents at the Hospital for mTBI
- NCT06033950 · 2,600 participants · Phase 3
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
- NCT06574672 · 2,600 participants · NA
Embedded Palliative Care in the MICU
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI